These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7125797)
21. Circulating immune complexes in patients with leprosy. Park JY; Kim KW; Kim SJ; Kim JD Yonsei Med J; 1984; 25(1):18-26. PubMed ID: 6544535 [No Abstract] [Full Text] [Related]
22. B lymphocytes in lepromatous leprosy. Gajl-Peczalska KJ; Lim SD; Jacobson RR; Good RA N Engl J Med; 1973 May; 288(20):1033-5. PubMed ID: 4572304 [No Abstract] [Full Text] [Related]
23. Serological abnormalities in Japanese patients with borderline leprosy. Furukawa F; Kohno A; Hamashima Y Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):96-8. PubMed ID: 6608504 [No Abstract] [Full Text] [Related]
25. Associations of circulating immune complexes, clinical activity, and bacterial index in Japanese patients with leprosy. Furukawa F; Ozaki M; Imamura S; Yoshida H; Pinrat A; Hamashima Y Arch Dermatol Res; 1982; 274(1-2):185-8. PubMed ID: 7165365 [No Abstract] [Full Text] [Related]
26. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589 [TBL] [Abstract][Full Text] [Related]
33. IgG response to some mycobacterial antigens in selected leprosy patients. Rafi A Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):567-71. PubMed ID: 10437959 [TBL] [Abstract][Full Text] [Related]
35. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions. Beuria MK; Mohanty KK; Katoch K; Sengupta U Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917 [TBL] [Abstract][Full Text] [Related]
36. Identification of "high risk group" of leprosy in children using serological and lepromin test: a preliminary report. Naik SS; Ganapati R; Shah DH; Dandekar SR; Sahasrabudhe RV Indian J Lepr; 1989 Apr; 61(2):173-5. PubMed ID: 2746025 [No Abstract] [Full Text] [Related]
37. [Evaluation of circulating immune complexes in leprosy in relation to clinical activity, antileprosy agents, bacterial indices and anti-DNA antibodies]. Furukawa F; Hamashima Y; Ozaki M Nihon Rai Gakkai Zasshi; 1983; 52(2):102-10. PubMed ID: 6678925 [No Abstract] [Full Text] [Related]
38. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy. Hussain R; Dockrell HM; Chiang TJ Immunology; 1994 Nov; 83(3):495-500. PubMed ID: 7835976 [TBL] [Abstract][Full Text] [Related]
39. Circulating immune complexes in carcinoma of the pancreas. Mihas AA; Volanakis JE; Schrohenloher RE; Mihas TA Anticancer Res; 1981; 1(3):155-8. PubMed ID: 7342854 [TBL] [Abstract][Full Text] [Related]
40. Lymphocytotoxins in leprosy and in asymptomatic hepatitis B virus infection. Serjeantson S; Dry P Clin Exp Immunol; 1980 Feb; 39(2):289-96. PubMed ID: 7389201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]